An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)
- Status
- COMPLETED
- Phase
- PHASE2
Neuroendocrine and Adrenal Tumors
- Status
- WITHDRAWN
- Phase
- N/A
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET
- Status
- COMPLETED
- Phase
- PHASE2
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
- Status
- COMPLETED
- Phase
- N/A
TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets
- Status
- COMPLETED
- Phase
- PHASE2
CapTemY90 for Grade 2/3 NET Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Portal Vein Resection in Pancreatic Neuroendocrine Tumours
- Status
- UNKNOWN
- Phase
- N/A
Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment
- Status
- UNKNOWN
- Phase
- N/A
Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.
- Status
- WITHDRAWN
- Phase
- PHASE2
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE1
18F-AmBF3-TATE PET/CT for Imaging NET Patients
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib and Nivolumab for Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
- Status
- UNKNOWN
- Phase
- PHASE2